Edition:
United States

Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

86.80SEK
25 Sep 2017
Change (% chg)

-- (--)
Prev Close
86.80kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,592,682
52-wk High
95.90kr
52-wk Low
70.00kr

Latest Key Developments (Source: Significant Developments)

Elekta inks 8-year deal with GenesisCare for more than $100 mln
Thursday, 31 Mar 2016 01:40am EDT 

Elekta publ AB:Signed an eight-year partnership deal worth more than $100 million with Australian radiotherapy firm GenesisCare.Says will book no part of the agreement in Q4.Deal includes the acquisition of solutions across Elekta's portfolio.Says expects GenesisCare to order its new MRI-guided linear accelerator when it becomes available on the market in 2017.  Full Article

Elekta publ AB wins order worth over 5 million pounds
Monday, 30 Nov 2015 01:30am EST 

Elekta publ AB:Proton Partners International to fight cancer with Elekta radiotherapy equipment.Elekta says order is valued at more than 5 million British pounds and was booked during Elekta's second fiscal quarter.  Full Article

Karolinska University Hospital to purchase Elekta 's Leksell Gamma Knife Icon
Wednesday, 25 Nov 2015 01:30am EST 

Elekta publ AB:Karolinska University Hospital to purchase Elekta's Leksell Gamma Knife Icon.  Full Article

Elekta publ AB staff arrested in Italy in contract rigging probe - Reuters
Thursday, 12 Nov 2015 05:19am EST 

Elekta publ AB:Four senior employees of Swedish medical technology group Elektahave been placed under house arrest in Italy over an investigation into alleged contract rigging and criminal association, the Milan prosecutors' office said on Thursday - RTRS.Elekta, which makes equipment for cancer treatment, was not immediately available for comment - RTRS.As well as the four managers under house arrest, 22 other people were placed under investigation, the prosecutors' office said, and Elekta SpA, the Italian arm of the Swedish group, is also being investigated - RTRS.  Full Article

Elekta affirms financial targets for coming years
Monday, 19 Oct 2015 10:10am EDT 

Elekta publ AB:Says reiterated plan to reduce costs by 450 million Swedish crowns, as well as ambition to improve EBITA margin with 6 percentage points by FY 2017/18 at a Capital Markets Presentation during the American Society for Radiation Oncology (ASTRO) Annual Meeting.Says reiterated expected mid-term market growth rate of 3-5 percent per year.Says the comprehensive action program launched earlier this fiscal year is on track.  Full Article

BRIEF- IBA and Elekta enter MOU regarding comprehensive partnership

* ANNOUNCED ON SATURDAY IBA AND ELEKTA ENTERED A MEMORANDUM OF UNDERSTANDING (MOU)REGARDING A COMPREHENSIVE PARTNERSHIP INCLUDING JOINT SOFTWARE DEVELOPMENT AND SALES TO ADVANCE PROTON THERAPY TREATMENTS Source text for Eikon: